title: Central precocious puberty due to hypothalamic hamartomas correlates with anatomic features but not with expression of GnRH, TGFalpha, or KISS1.
abstract: OBJECTIVE
  Hypothalamic hamartomas are the most common identifiable cause of central precocious puberty (CPP). Hamartoma characteristics proposed to be associated with CPP include specific anatomic features and expression of molecules such as gonadotropin-releasing hormone (GnRH), transforming growth factor alpha (TGFalpha), and GRM1A, which encodes the type 1 metabotropic glutamate receptor alpha isoform. We sought to determine whether hamartomas that cause CPP could be distinguished by anatomic features, expression of these molecules, or expression of KISS1, whose products signal through the receptor GPR54 to stimulate GnRH release.
  
  
  METHODS
  Clinical records and radiologic images were reviewed for 18 patients who underwent hamartoma resection for intractable seizures; 7 had precocious puberty. Resected tissue was examined for expression of GnRH, GnRH receptor (GnRHR), TGFalpha, KISS1, GPR54, and GRM1A.
  
  
  RESULTS
  Hypothalamic hamartomas associated with CPP were more likely to contact the infundibulum or tuber cinereum and were larger than hamartomas not associated with CPP. GnRH, TGFalpha, and GnRHR were expressed by all hamartomas studied. Expression of KISS1, GPR54, and GRM1A did not differ significantly between hamartomas associated and not associated with CPP.
  
  
  CONCLUSIONS
  Anatomic features rather than expression patterns of candidate molecules distinguish hypothalamic hamartomas that are associated with CPP from those that are not.
authors.affiliation: Harvard Reproductive Sciences Center and Reproductive Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. ymchan@partners.org
authors.forename: Yee-Ming
authors.initials: YM
authors.lastname: Chan
authors.forename: Kristina A
authors.initials: KA
authors.lastname: Fenoglio-Simeone
authors.forename: Sophia
authors.initials: S
authors.lastname: Paraschos
authors.forename: Laura
authors.initials: L
authors.lastname: Muhammad
authors.forename: Matthew M
authors.initials: MM
authors.lastname: Troester
authors.forename: Yu-Tze
authors.initials: YT
authors.lastname: Ng
authors.forename: Roger E
authors.initials: RE
authors.lastname: Johnsonbaugh
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Coons
authors.forename: Erin C
authors.initials: EC
authors.lastname: Prenger
authors.forename: John F
authors.initials: JF
authors.lastname: Kerrigan
authors.forename: Stephanie B
authors.initials: SB
authors.lastname: Seminara
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D015870:Gene Expression; D007987:Gonadotropin-Releasing Hormone / Q000096:biosynthesis*; D006222:Hamartoma / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D006801:Humans; D007027:Hypothalamic Diseases / Q000150:complications* / Q000000981:diagnostic imaging / Q000473:pathology; D007223:Infant; D059648:Kisspeptins; D008297:Male; D011629:Puberty, Precocious / Q000209:etiology* / Q000473:pathology; D011859:Radiography; D011966:Receptors, LHRH / Q000096:biosynthesis; D012640:Seizures / Q000209:etiology / Q000601:surgery; D016211:Transforming Growth Factor alpha / Q000096:biosynthesis*; D025521:Tumor Suppressor Proteins / Q000096:biosynthesis*
chemical_list: C106628:KISS1 protein, human; D059648:Kisspeptins; D011966:Receptors, LHRH; D016211:Transforming Growth Factor alpha; D025521:Tumor Suppressor Proteins; D007987:Gonadotropin-Releasing Hormone
references.citation: Minim Invasive Neurosurg. 2002 Dec;45(4):235-9
references.pmid: 12494360
references.citation: Pediatrics. 1981 Feb;67(2):236-44
references.pmid: 7243449
references.citation: Epilepsia. 2006 Jul;47(7):1192-202
references.pmid: 16886983
references.citation: Horm Res. 2001;56(1-2):12-8
references.pmid: 11815722
references.citation: Neurol Med Chir (Tokyo). 2005 May;45(5):221-31
references.pmid: 15914961
references.citation: Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9743-7
references.pmid: 1946396
references.citation: J Neurophysiol. 2007 Jul;98(1):5-15
references.pmid: 17428906
references.citation: Ann Neurol. 2005 Sep;58(3):371-82
references.pmid: 16130091
references.citation: JAMA. 1984 May 4;251(17):2247-9
references.pmid: 6368884
references.citation: Neurosurgery. 1994 Jun;34(6):949-58; discussion 958
references.pmid: 8084405
references.citation: AJNR Am J Neuroradiol. 2004 Mar;25(3):450-62
references.pmid: 15037472
references.citation: Proc Natl Acad Sci U S A. 1990 Dec;87(24):9698-702
references.pmid: 2263621
references.citation: Nature. 2008 Apr 3;452(7187):564-70
references.pmid: 18385730
references.citation: J Clin Endocrinol Metab. 2003 Oct;88(10):4590-5
references.pmid: 14557427
references.citation: J Clin Endocrinol Metab. 1999 Dec;84(12):4695-701
references.pmid: 10599738
references.citation: Noshuyo Byori. 1995 Mar;12(1):45-51
references.pmid: 7795729
references.citation: J Neuropathol Exp Neurol. 2007 Feb;66(2):131-41
references.pmid: 17278998
references.citation: N Engl J Med. 1977 Jan 6;296(1):7-10
references.pmid: 318592
references.citation: Pediatr Neurosci. 1987;13(1):19-26
references.pmid: 3120166
references.citation: Horm Res. 2008;69(2):114-23
references.pmid: 18059092
references.citation: J Neuropathol Exp Neurol. 2008 Jul;67(7):657-68
references.pmid: 18596547
references.citation: Neurol Med Chir (Tokyo). 2003 Feb;43(2):61-8
references.pmid: 12627881
references.citation: N Engl J Med. 2008 Feb 14;358(7):709-15
references.pmid: 18272894
references.citation: Endocr Dev. 2005;8:81-93
references.pmid: 15722619
references.citation: Neurosurgery. 1985 Sep;17(3):408-12
references.pmid: 3900794
references.citation: Trends Neurosci. 2007 Oct;30(10):504-11
references.pmid: 17904653
references.citation: Horm Res. 2007;68 Suppl 5:75-9
references.pmid: 18174715